Medicare Enrolled
Dr. Jason Ho, M.D.
Hematology & Oncology · Los Angeles, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ho?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ho
Dr. Jason Ho is a hematology & oncology specialist in Los Angeles, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Ho performed 11,965 Medicare services across 1,719 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ho received a total of $41,628 from 99 pharmaceutical and/or device companies across 1611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ho is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 27% volume in CA
$41,628 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,965
Medicare services
Top 27% in CA for hematology & oncology
1,719
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~665 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,635 | $18 | $69 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,730 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,099 | $101 | $415 |
| Anti-nausea injection (ondansetron/Zofran) | 791 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
561 | $8 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
539 | $64 | $286 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
451 | $4 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
444 | $12 | $48 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
394 | $1 | $4 |
| Anti-nausea injection (Aloxi/palonosetron) | 355 | $1 | $2 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
246 | $10 | $34 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
185 | $8 | $16 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
180 | $0 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
177 | $25 | $102 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
167 | $27 | $115 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
167 | $118 | $469 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
163 | $100 | $377 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
156 | $47 | $228 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
136 | $3 | $16 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
126 | $9 | $44 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
110 | $1 | $4 |
| New patient office visit, complex (60-74 min) | 50 | $170 | $720 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
31 | $34 | $131 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
26 | $14 | $54 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $143 | $590 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
21 | $145 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.9% high complexity
62.2% medium
29.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$41,628
Total received (2018-2024)
Avg $5,947/year across 7 years
Top 13% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
99
Companies
1,611
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$38,135 (91.6%)
Other
Charitable contributions, space rental, and other categories
$2,299 (5.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,028 (2.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$166 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,404
2023
$6,947
2022
$4,757
2021
$3,611
2020
$4,296
2019
$5,550
2018
$9,062
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,390
AstraZeneca Pharmaceuticals LP
$611
Takeda Pharmaceuticals U.S.A., Inc.
$374
PFIZER INC.
$349
Merck Sharp & Dohme LLC
$342
Incyte Corporation
$257
ARRAY BIOPHARMA INC
$247
Daiichi Sankyo Inc.
$237
Janssen Biotech, Inc.
$218
Celgene Corporation
$215
E.R. Squibb & Sons, L.L.C.
$211
Astellas Pharma US Inc
$206
Genentech USA, Inc.
$202
ABBVIE INC.
$164
ADC Therapeutics America, Inc.
$158
Gilead Sciences, Inc.
$151
SOBI, INC
$147
Regeneron Healthcare Solutions, Inc.
$143
TerSera Therapeutics LLC
$139
Exelixis Inc.
$135
JAZZ PHARMACEUTICALS INC.
$132
Karyopharm Therapeutics Inc.
$131
EMD Serono, Inc.
$123
Boehringer Ingelheim Pharmaceuticals, Inc.
$106
GENZYME CORPORATION
$102
GlaxoSmithKline, LLC.
$88
Deciphera Pharmaceuticals Inc.
$73
PUMA BIOTECHNOLOGY, INC.
$63
Bayer Healthcare Pharmaceuticals Inc.
$62
Ipsen Biopharmaceuticals, Inc
$55
Eisai Inc.
$51
RECORDATI_RARE_DISEASES_INC.
$50
Lilly USA, LLC
$50
SpringWorks Therapeutics, Inc.
$48
Boston Scientific Corporation
$47
PharmaEssentia USA Corporation
$44
Alexion Pharmaceuticals, Inc.
$43
Genmab U.S., Inc.
$34
Aveo Pharmaceuticals, Inc.
$30
Agios Pharmaceuticals, Inc.
$30
Blueprint Medicines Corporation
$26
Sumitomo Pharma America, Inc.
$25
Octapharma USA, Inc.
$22
Coherus Biosciences Inc.
$22
Novocure Inc.
$22
Cumberland Pharmaceuticals, Inc.
$15
Emmaus Medical, Inc.
$12
Top 3 companies account for 32.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$8,366
AstraZeneca Pharmaceuticals LP
$2,393
Amgen Inc.
$2,160
Genentech USA, Inc.
$1,648
E.R. Squibb & Sons, L.L.C.
$1,615
Celgene Corporation
$1,570
Incyte Corporation
$1,471
PFIZER INC.
$1,387
Puma Biotechnology, Inc.
$1,256
Exelixis Inc.
$1,048
Takeda Pharmaceuticals U.S.A., Inc.
$1,040
Janssen Biotech, Inc.
$954
GENZYME CORPORATION
$943
Merck Sharp & Dohme LLC
$827
Gilead Sciences, Inc.
$722
Seagen Inc.
$712
Boehringer Ingelheim Pharmaceuticals, Inc.
$601
Karyopharm Therapeutics Inc.
$586
Astellas Pharma US Inc
$552
Merck Sharp & Dohme Corporation
$504
TESARO, Inc.
$489
Daiichi Sankyo Inc.
$476
ARRAY BIOPHARMA INC
$471
Lilly USA, LLC
$428
Blueprint Medicines Corporation
$406
Regeneron Healthcare Solutions, Inc.
$401
Alexion Pharmaceuticals, Inc.
$356
TerSera Therapeutics LLC
$318
EMD Serono, Inc.
$315
Kite Pharma, Inc.
$309
GlaxoSmithKline, LLC.
$301
Dova Pharmaceuticals
$276
TOLMAR Pharmaceuticals, Inc.
$257
NOVARTIS PHARMACEUTICALS CORPORATION
$250
JAZZ PHARMACEUTICALS INC.
$243
Pharmacyclics LLC, An AbbVie Company
$243
Spectrum Pharmaceuticals Inc.
$239
Eisai Inc.
$236
ADC Therapeutics America, Inc.
$226
MorphoSys, US Inc.
$219
Seattle Genetics, Inc.
$215
PUMA BIOTECHNOLOGY, INC.
$207
PharmaEssentia USA Corporation
$198
ABBVIE INC.
$187
Pharmacosmos Therapeutics Inc.
$180
SOBI, INC
$175
EISAI INC.
$174
Foundation Medicine, Inc.
$165
Clovis Oncology, Inc.
$163
Rigel Pharmaceuticals, Inc.
$158
Ipsen Biopharmaceuticals, Inc
$149
Janssen Scientific Affairs, LLC
$145
Deciphera Pharmaceuticals Inc.
$142
Teva Pharmaceuticals USA, Inc.
$136
Coherus Biosciences Inc.
$132
Genmab U.S., Inc.
$130
Myovant Sciences Inc.
$123
Heron Therapeutics, Inc.
$117
Bayer Healthcare Pharmaceuticals Inc.
$113
AVEO Pharmaceuticals, Inc.
$110
Sumitomo Pharma America, Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$103
G1 Therapeutics, Inc.
$88
Janssen Products, LP
$85
Emmaus Medical, Inc.
$80
Sun Pharmaceutical Industries Inc.
$76
INSYS Therapeutics Inc
$72
Taiho Oncology, Inc.
$68
Helsinn Therapeutics (U.S.), Inc.
$64
Apellis Pharmaceuticals, Inc.
$56
BeiGene USA, Inc.
$55
Agios Pharmaceuticals, Inc.
$53
RECORDATI_RARE_DISEASES_INC.
$50
SpringWorks Therapeutics, Inc.
$48
Boston Scientific Corporation
$47
Verastem, Inc.
$44
Global Blood Therapeutics, Inc.
$42
R-Pharm US LLC
$39
Kyowa Kirin, Inc.
$39
EUSA Pharma (US) LLC
$39
Chiesi USA, Inc.
$37
Alnylam Pharmaceuticals Inc.
$33
Adaptive Biotechnologies Corporation
$31
Sirtex Medical Inc
$31
Aveo Pharmaceuticals, Inc.
$30
GE HealthCare
$29
AMAG Pharmaceuticals, Inc.
$25
Lexicon Pharmaceuticals, Inc.
$24
Octapharma USA, Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$22
Roche Molecular Systems, Inc.
$22
Novocure Inc.
$22
Mylan Pharmaceuticals Inc.
$20
Acrotech Biopharma LLC
$19
Stemline Therapeutics Inc.
$17
Organon LLC
$16
Cumberland Pharmaceuticals, Inc.
$15
West Therapeutics Development, LLC
$14
Array BioPharma Inc.
$13
Top 3 companies account for 31.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALOXI · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DIAGNOSTICS INFORMATION SYSTEMS · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FERRIPROX · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · Inrebic · Itovebi · Ixempra · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETACRIT · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNDROS · Somatuline Depot · Stivarga · Subsys · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIIHERA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
406
Per 100K population
4.1
County median income
$87,760
Nearest hospital
PIH HEALTH GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ho is a mixed practice specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ho experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Ho performed 3,635 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ho receive payments from pharmaceutical companies?
Yes. Dr. Ho received a total of $41,628 from 99 companies across 1,611 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ho's costs compare to other hematology & oncology specialists in Los Angeles?
Dr. Ho's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Los Angeles
Browse hematology & oncology specialists in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology